Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) partner Sarepta Therapeutics, Inc. (SRPT) has gone through a lot in the last two weeks. First, Sarepta announced a restructuring and pipeline ...

After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy to ambulatory people but maintain a halt it implemented June 15 for ...